Saturation biopsy for detecting and characterizing prostate cancer.
about
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.Targeted prostate biopsy and MR-guided therapy for prostate cancer.Variable correlation of grid coordinates to core location in template prostate biopsy.Hematoma in Retzius' space following US-guided prostate biopsy: evidence of the diagnostic accuracy using transrectal end-fire probe in the anterior prostate gland.Screening and diagnosis of prostate cancer in patients with ileal pouch-anal anastomosis: consensus from an expert panel.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer.Prostate saturation biopsy following a first negative biopsy: state of the art.Random biopsy: when, how many and where to take the cores?MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer.Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer.Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.Are repeat prostate biopsies safe? A cohort analysis from the SEARCH databaseThe Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy.Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three-dimensional analysis.A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy.Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era
P2860
Q33863562-5C26D01A-2F7D-443A-9586-2EBAFCCE88FDQ34406115-55436BEF-6DC0-442A-A40A-B08DC3AB8FC3Q35933229-6BADD891-AB7F-456B-8FEF-E1C384E3DBD7Q37198126-35EAE5F8-719B-4BFA-839B-8827B61D1E4AQ37622343-CABD8B46-CA98-4206-803E-5CC8E03E43E3Q37837466-E1482B14-CEA1-47C8-AA35-DE06EB5ECDCFQ37892629-6492FEE1-B82E-424B-85AA-D3A9885A6D5CQ37972704-AF30190A-0AAB-427A-9D9A-074BBC3E4BD9Q38027698-72A390C5-FE85-43D5-AAF6-32491BBB2254Q38218443-E5F76FCA-9947-45B6-BBF3-179F8F168281Q38943188-BC69706F-312C-4756-BB9C-92FC151BF47BQ39356200-594FF044-0D59-4733-A85E-AD788A6143DBQ39477975-EDD271B9-7FD5-4503-997F-EA9F7D6A59F7Q40029512-DD0EB8CF-7FF1-436A-8A7E-63C6405616A4Q40460159-5AD48071-5A01-4BD7-9886-483EED563FEEQ41907809-84DA09CC-286F-4F20-94B1-B3AC595C3025Q45940658-14BE1966-B790-4C85-AF55-EC05CB891A4CQ46922611-A5C9ED88-735D-4B26-B28E-231951422999Q47833550-CA0DCC76-1B50-4447-BC6B-70C1442F0894Q57646485-0ACACB8A-9AEC-4094-8D86-DFAA52003146
P2860
Saturation biopsy for detecting and characterizing prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Saturation biopsy for detecting and characterizing prostate cancer.
@en
type
label
Saturation biopsy for detecting and characterizing prostate cancer.
@en
prefLabel
Saturation biopsy for detecting and characterizing prostate cancer.
@en
P2860
P1433
P1476
Saturation biopsy for detecting and characterizing prostate cancer.
@en
P2093
J Stephen Jones
P2860
P304
P356
10.1111/J.1464-410X.2007.06868.X
P577
2007-04-08T00:00:00Z